Real-time enrollment status for this hematopoietic and lymphoid cell neoplasm clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 12:12 PM UTC
| NCT Number | NCT05711667 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphoid Cell Neoplasm |
| Phase | PHASE3 |
| Target Enrollment | 105 participants |
| Active Locations | 33 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | October 6, 2026 (1 week ago) |
As of October 14, 2026: Clinical trial NCT05711667 is currently recruiting participants. This phase3 study for hematopoietic and lymphoid cell neoplasm is actively seeking new participants at 33 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05711667 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05711667 was last updated 1 week ago (October 6, 2026). HelloStudys verifies this status automatically.